SMMT Past Earnings image   This SMMT past earnings page last updated 2/22/2024
SMMT Past Earnings
PeriodPast Earnings DateGAAP
Q4 20232/20/2024-0.050
Q3 202311/7/2023-0.030
Q2 20238/9/2023-0.020
Q1 20235/11/2023-1.430
Q4 20223/9/2023-0.070
Q3 202211/9/2022-0.140
Q2 20228/11/2022-0.170
Q1 20225/11/2022-0.220
Q4 20213/17/2022-0.280
Q3 202111/15/2021-0.200
Q2 20218/11/2021-0.270
Q1 20215/17/2021-0.210
Q4 20203/17/2021-0.180
Q3 202011/16/2020-0.260
Q2 20209/29/2020-0.230
Q1 20206/2/2020-0.020
Q4 20194/30/2020-0.050
Q3 201912/17/2019-0.050
Q2 201910/11/2019-0.040
Q1 20196/12/2019-0.040
Q4 20183/27/2019-0.08
Q3 201812/11/2018-0.13
Q2 20189/20/20180.42
Q1 20186/5/2018-0.11
Q4 20174/11/2018-0.23
Q3 201712/6/20170
Q2 20178/31/20170.22
Q1 20176/14/2017-0.1
Q4 20163/29/2017-0.1
Q3 201612/15/2016-0.09
Q2 20169/8/2016-0.13
Q1 20165/10/2016-0.11
Q4 20151/15/2016-0.11
Q3 201512/17/2015-0.12
Q2 20158/27/2015-0.11
SMMT Past Revenue
PeriodPast Earnings DateGAAP
Q4 20232/20/2024NA
Q3 202311/7/2023NA
Q2 20238/9/2023NA
Q1 20235/11/2023NA
Q4 20223/9/2023NA
Q3 202211/9/20220.00B
Q2 20228/11/20220.00B
Q1 20225/11/20220.00B
Q4 20213/17/20220.00B
Q3 202111/15/20210.00B
Q2 20218/11/20210.06M
Q1 20215/17/20210.00B
Q4 20203/17/20210.00B
Q3 202011/16/20200.00B
Q2 20209/29/20200.00B
Q1 20206/2/20200.00B
Q4 20194/30/20200.00B
Q3 201912/17/20190.00B
Q2 201910/11/20190.00B
Q1 20196/12/20190.00B
Q4 20183/27/20190.00B
Q3 201812/11/2018863000
Q2 20189/20/201849.82M
Q1 20186/5/20185.33M
Q4 20174/11/20184.27M
Q3 201712/6/20172.29M
Q2 20178/31/201725.01M
Q1 20176/14/20172.24M
Q4 20163/29/20172.17M
Q3 201612/15/2016703000
Q2 20169/8/201622000
Q1 20165/10/2016344000
Q4 20151/15/2016NA
Q3 201512/17/2015NA
Q2 20158/27/2015NA
Quotes delayed 20 minutes

Email EnvelopeFree SMMT Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 Most Oversold S&P 500 Stocks
10 Most Overbought S&P 500 Stocks
10 ETFs With Stocks Insiders Are Buying
10 ETFs With Most Upside To Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active S&P Call & Put Options
Summit Therapeutics (SMMT) is categorized under the Healthcare sector; to help you further research past earnings across stocks, below are some other companies in the same sector:

SMTI Past Earnings
SNDA Past Earnings
SNDX Past Earnings
SNGX Past Earnings
SNOA Past Earnings
SNPX Past Earnings
SNSE Past Earnings
SOLY Past Earnings
SONN Past Earnings
SONX Past Earnings

SMMT Past Earnings Q&A

What was the best and worst SMMT past earnings results?
For Summit Therapeutics, I'm wondering what the company's very best and worst earnings results have been, on an earnings per share basis?

✔️Accepted answer: The highest SMMT past earnings result in our data set was 0.42/share posted in Q2 2018, while the lowest was in Q1 2023 when SMMT posted -1.430/share.

  Suggested answer: The biggest top line earnings performance — aka revenue — quarter was in Q2 2018 when SMMT reported 49.82M in revenue, while the quarter with the lowest revenue in our data set was Q4 2023 at NA of revenue.

  Suggested answer: There are 35 SMMT past earnings results in our data set.

On this page we presented the SMMT past earnings date information for Summit Therapeutics. Reviewing that SMMT Past Earnings for the company, we see that the highest past earnings result in our data set was in Q2 2018, when SMMT posted gaap of 0.42/share. Meanwhile the lowest SMMT past earnings result was in Q1 2023, when SMMT posted gaap of -1.430/share. Turning to top line revenue performance, the biggest revenue quarter in our data set was seen in Q2 2018 when SMMT reported 49.82M in revenue, while the smallest revenue quarter was Q4 2023 when SMMT reported NA in revenue.

Any self directed investor doing their due diligence on SMMT or any other given stock can benefit from researching all of the Summit Therapeutics past earnings — and here, we present each quarter's result all together on one page for easy comparison. Studying this information can help when projecting future earnings, as well as determining whether the past earnings trajectory justifies the current stock value. That's why we bring you to make it easy for investors to investigate Summit Therapeutics past earnings, or the past earnings information for any stock in our coverage universe. And in your continued research we hope you will be sure to check out the further links included for earnings surprises history (beat/miss data) as well as next earnings dates for SMMT. Thanks for visiting, and the next time you need to research SMMT past earnings or those of another stock, we hope you'll think of our site, as your go-to past earnings research resource of choice.

Recommended: Funds Holding MAG, CGC shares outstanding history, BLK shares outstanding history.


SMMT Past Earnings | | Copyright © 2020 - 2024, All Rights Reserved

Nothing in is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
Wait! Don't leave yet.
Want to receive our latest research absolutely free?

Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 9.5%—Every Month—Forever.

You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 9.5%.